Arkolith/Insider Trading/BMRN/Form 4

Friberg Gregory R

EVP, Chief R&D OfficerBIOMARIN PHARMACEUTICAL INC (BMRN) · full profile →Form 4 · filed Feb 26, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$382K
Net Open-Market Flow
-$382K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 26, 2026Sell(S)6K$60.38$382K38K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-012539) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML